Career Development Program

对我们的CDP计划的审查是积极的，并指出“所描述的潜在候选人非常强大”。 然而，我们对高级博士后研究员资金来源的依赖被认为是“不一致的” 因此，我们修订了整个CDP，以便更清楚地提供研究 支持高级研究员、初级教员和资深研究人员，他们希望发展或重新关注他们的 从事转译乳腺癌研究的职业。CDP通过汤姆森基金会为研究人员提供支持 家庭奖学金将仅用于支持向独立研究员过渡的研究员 教职员工预约。 在这份意见书中，我们已经明确了我们的目标和我们对孢子指南的遵守。我们的建议 计划详细描述了对以下项目感兴趣并表示承诺的有前途的个人 转译乳腺癌研究将被选中。它进一步阐述了CDP领导层将如何寻求 并招募合格的妇女和少数族裔参加该计划。 更具体地说，CDP领导层将使用项目资金来招募和培养合格的调查人员 级别。CDP领导人将提供一个系统，在广泛的学科和领域指导这些人 建立一个框架，使调查人员能够接触到，并可能在以下方面进行培训 在他们的专业领域之外的转译乳腺癌研究。确保创新的想法可以 在乳腺癌研究中发展成有前途的翻译研究，妇女、少数族裔和 培养能够对FHCRC和FHCRC的转译乳腺癌研究做出关键贡献的教师 UW，被大力招募和保留也是当前计划的关键目标。 在对这一评论的回应中：“尽管对多样性的承诺没有受到质疑，但有一段 说明FHCRC/UW的研究方案的性别/少数群体构成没有包括在内“， 我们在C.2节增加了两个表，以解决这一疏忽问题。第一个介绍了民族的细分 自2008年12月31日起，我校教师、博士后候选人和博士后研究生将继续留学。第二 提供华盛顿大学医学院(UWSOM)2007年按种族划分的入学人数。

The review of our CDP plan was positive and noted that the "potential candidates described were very strong." However, our reliance on a funding source for senior level post-doctoral fellows was considered "not consistent with the SPORE guidelines." We have therefore revised the entire CDP to more cleariy provide research support for advanced fellows, junior faculty and established investigators who wish to develop or refocus their careers on translational breast cancer research. CDP support for research fellows through the Thomsen Family Fellowship will be used only when it is for support of research fellows transitioning to independent faculty appointments. In this submission, we have clarified our goals and our adherence to the SPORE guidelines. Our proposed plan describes in detail how promising individuals with an interest in, and expressed commitment to, translational breast cancer research will be selected. It further addresses how the CDP leadership will seek out and recruit qualified women and minorities for participation in the program. More specifically, the CDP Leadership will use program funds to recruit and nurture qualified investigators at all levels. CDP leaders will provide a system for mentoring such individuals in a broad range of disciplines and create a framework in which investigators can gain exposure to, and possibly training in, aspects of translational breast cancer research outside their areas of expertise. Ensuring that innovative ideas can develop into promising translational studies in breast cancer research, and that women, minorities and developing faculty who can make key contributions to translational breast cancer research at the FHCRC and UW, are strongly recruited and retained are also key goals ofthe current plan. In a response to the comment: "Although the commitment to diversity is not questioned, a paragraph stating the gender/minority composition ofthe research programs at FHCRC/UW was not included", we have added two tables to section C.2 to address this oversight. The first presents the ethnic breakdown of faculty, postdoctoral candidates and pre-doctoral students at FHCRC as of December 31, 2008. The second provides enrollment figures by ethnicity for the UW School of Medicine (UWSOM) in 2007.